Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1982-09-30
1984-04-10
Schwartz, Richard A.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
544360, A61K 31495
Patent
active
044421036
ABSTRACT:
1-(3-Substituted-2-pyridinyl)piperazines and their acid addition salts are selective .alpha..sub.2 -adrenergic receptor antagonists and thereby useful as antidepressant agents and for treating sedation caused by antihypertensive therapy.
REFERENCES:
patent: 2958694 (1960-11-01), Jannsen
patent: 3773951 (1973-11-01), Rodriguez
patent: 4078063 (1978-03-01), Lumma et al.
patent: 4081542 (1978-04-01), Lumma et al.
patent: 4082844 (1978-04-01), Lumma et al.
patent: 4310524 (1982-01-01), Wiech et al.
Thunus; L. et al., Ann. Pharm. Fran., 32, 569-574 (1974).
Merck & Co. , Inc.
Monaco Mario A.
Nicholson William H.
Schwartz Richard A.
LandOfFree
Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treating sedation with 1-(3-substituted-2-pyridinyl) piperazines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-892514